AI assistant
Hester Biosciences Ltd — Call Transcript 2021
Aug 9, 2021
62222_rns_2021-08-09_223867ae-2457-4abc-83ca-9d39d3e8d1d2.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [522 x 96] intentionally omitted <==
09.08.2021
To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524669
To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051
Symbol: HESTERBIO
Respected Sir/ Madam:
Subject: Intimation of earnings conference call
This is to inform you that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Thursday, 12 August 2021 at 2:00 p.m. (IST) to discuss the standalone and consolidated unaudited financial results for the quarter ended 30 June 2021.
You are requested to take the above on record.
Sincerely For Hester Biosciences Limited Vinod Mali Company Secretary & Compliance Officer
==> picture [198 x 32] intentionally omitted <==
is pleased to invite you to the
Q1FY22 Results Conference Call
of
==> picture [73 x 73] intentionally omitted <==
Hester Biosciences Limited
Represented by
\
Mr. Rajiv Gandhi, CEO & Managing Director Mr. Nikhil Jhanwar, Chief Financial Officer
on
Thursday, August 12, 2021 At 14:00 hrs India Time
Diamond Pass registration link: Copy this Link in your browser: Link
Call Co-ordinator:
Mr. Sriraam Rathi: Phone: +91 22 6637 7574, e-mail: [email protected] Mr. Vinay Bafna: Phone: +91 22 6637 7339, e-mail: [email protected]
For any clarification, please contact:
Mr. Rushad Kapadia: Phone: +91 22 6637 7334, e-mail: [email protected] Ms. Divya Purohit: Phone: +91 22 6637 7454, e-mail: [email protected] Ms. Seema Sehgal: Phone: +91 11 4221 8511, e-mail: [email protected]